{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:03:32Z","timestamp":1740107012512,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-022-02657-8","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T01:02:19Z","timestamp":1660784539000},"page":"3141-3146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A good surgical field for para-aortic nodal dissection in gastric cancer by the Cattell-Braasch maneuver"],"prefix":"10.1007","volume":"407","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5614-3148","authenticated-orcid":false,"given":"Masayuki","family":"Akita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Kozuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiko","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"2657_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1470-2045(06)70623-4","volume":"7","author":"CW Wu","year":"2006","unstructured":"Wu CW, Hsiung CA, Lo SS et al (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7:309\u2013315","journal-title":"Lancet Oncol"},{"key":"2657_CR2","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810\u20131820","journal-title":"N Engl J Med"},{"key":"2657_CR3","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","volume":"29","author":"M Sasako","year":"2011","unstructured":"Sasako M, Sakuramoto S, Katai H et al (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29:4387\u20134393","journal-title":"J Clin Oncol"},{"key":"2657_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1056\/NEJMoa0707035","volume":"359","author":"M Sasako","year":"2008","unstructured":"Sasako M, Sano T, Yamamoto S et al (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359:453\u2013462","journal-title":"N Engl J Med"},{"key":"2657_CR5","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.ejso.2016.01.002","volume":"42","author":"S Morita","year":"2016","unstructured":"Morita S, Fukagawa T, Fujiwara H, Katai H (2016) The clinical significance of para-aortic nodal dissection for advanced gastric cancer. Eur J Surg Oncol 42:1448\u20131454","journal-title":"Eur J Surg Oncol"},{"key":"2657_CR6","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1245\/s10434-010-0969-4","volume":"17","author":"M Tokunaga","year":"2010","unstructured":"Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Aikou S, Yamaguchi T (2010) Can superextended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes? Ann Surg Oncol 17:2031\u20132036","journal-title":"Ann Surg Oncol"},{"key":"2657_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1245\/ASO.2006.07.015","volume":"13","author":"C Kunisaki","year":"2006","unstructured":"Kunisaki C, Akiyama H, Nomura M et al (2006) Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study. Ann Surg Oncol 13:659\u2013667","journal-title":"Ann Surg Oncol"},{"key":"2657_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00280-010-1296-y","volume":"67","author":"IH Park","year":"2011","unstructured":"Park IH, Kim SY, Kim YW et al (2011) Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement. Cancer Chemother Pharmacol 67:127\u2013136","journal-title":"Cancer Chemother Pharmacol"},{"key":"2657_CR9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/jjco\/hyh120","volume":"34","author":"M Yoshida","year":"2004","unstructured":"Yoshida M, Ohtsu A, Boku N et al (2004) Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study. Jpn J Clin Oncol 34:654\u2013659","journal-title":"Jpn J Clin Oncol"},{"key":"2657_CR10","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/bjs.6665","volume":"96","author":"T Yoshikawa","year":"2009","unstructured":"Yoshikawa T, Sasako M, Yamamoto S et al (2009) Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg 96:1015\u20131022","journal-title":"Br J Surg"},{"key":"2657_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/bjs.9484","volume":"101","author":"A Tsuburaya","year":"2014","unstructured":"Tsuburaya A, Mizusawa J, Tanaka Y et al (2014) Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg 101:653\u2013660","journal-title":"Br J Surg"},{"key":"2657_CR12","doi-asserted-by":"crossref","unstructured":"Japanese Gastric Cancer Association. (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 14:101\u2013112","DOI":"10.1007\/s10120-011-0041-5"},{"key":"2657_CR13","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/jso.25892","volume":"121","author":"M Akita","year":"2020","unstructured":"Akita M, Yamasaki N, Miyake T et al (2020) Cattell-Braasch maneuver facilitates the artery-first approach and complete excision of the mesopancreas for pancreatoduodenectomy. J Surg Oncol 121:1126\u20131131","journal-title":"J Surg Oncol"},{"key":"2657_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12893-021-01338-5","volume":"21","author":"M Akita","year":"2021","unstructured":"Akita M, Maeda E, Nishimura T et al (2021) Anatomical change of SMV branches after the Cattell Braasch maneuver facilitates safe resection around the uncinated process in pancreatoduodenectomy. BMC surg 21:341","journal-title":"BMC surg"},{"key":"2657_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.21873\/anticanres.14855","volume":"41","author":"Y Shimoda","year":"2021","unstructured":"Shimoda Y, Fujikawa H, Komori K et al (2021) Prognostic factors for gastric cancer patients with one stage IV factor who underwent conversion surgery. Anticancer Res 41:1005\u20131012","journal-title":"Anticancer Res"},{"key":"2657_CR16","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.1245\/s10434-019-07790-1","volume":"26","author":"S Sato","year":"2019","unstructured":"Sato S, Kunisaki C, Tanaka Y et al (2019) Curative-intent surgery for stage IV advanced gastric cancer: who can undergo surgery and what are the prognostic factors for long-term survival? Ann Surg Oncol 26:4452\u20134463","journal-title":"Ann Surg Oncol"},{"key":"2657_CR17","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.ejso.2015.04.021","volume":"41","author":"J Kinoshita","year":"2015","unstructured":"Kinoshita J, Fushida S, Tsukada T et al (2015) Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer. Eur J Surg Oncol 41:1354\u20131360","journal-title":"Eur J Surg Oncol"},{"key":"2657_CR18","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S1470-2045(14)70473-5","volume":"15","author":"SH Noh","year":"2014","unstructured":"Noh SH, Park SR, Yang HK et al (2014) Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol 15:1389\u20131396","journal-title":"Lancet Oncol"},{"key":"2657_CR19","first-page":"378","volume":"111","author":"RB Cattell","year":"1960","unstructured":"Cattell RB, Braasch JW (1960) A technique for the exposure of the third and fourth portions of the duodenum. Surg Gynecol Obstet 111:378\u2013379","journal-title":"Surg Gynecol Obstet"},{"key":"2657_CR20","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1200\/JCO.2004.10.184","volume":"22","author":"T Sano","year":"2004","unstructured":"Sano T, Sasako M, Yamamoto S et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy\u2014Japan Clinical Oncology Group Study 9501. J Clin Oncol 22:2767\u20132773","journal-title":"J Clin Oncol"},{"key":"2657_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s10120-016-0619-z","volume":"20","author":"S Ito","year":"2017","unstructured":"Ito S, Takeshi Sano T, Junki Mizusawa J et al (2017) A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para- aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. Gastric Cancer 20:322\u2013331","journal-title":"Gastric Cancer"},{"key":"2657_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/0002-9610(74)90079-8","volume":"128","author":"KL Mattox","year":"1974","unstructured":"Mattox KL, McCollum WB, Jordan GL et al (1974) Management of upper abdominal vascular trauma. Am J Surg 128:823\u2013828","journal-title":"Am J Surg"},{"key":"2657_CR23","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","volume":"390","author":"YK Kang","year":"2017","unstructured":"Kang YK, Boku N, Satoh T et al (2017) Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390:2461\u20132471","journal-title":"Lancet"},{"key":"2657_CR24","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1158\/1078-0432.CCR-15-1136","volume":"22","author":"MF Keller","year":"2016","unstructured":"Keller MF, Kim Y, Cronin H, Richards A, Gibney G, Weber JS (2016) Nivolumab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes. Clin Cancer Res 22:886\u2013894","journal-title":"Clin Cancer Res"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-022-02657-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-022-02657-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-022-02657-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T22:17:04Z","timestamp":1667859424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-022-02657-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["2657"],"URL":"https:\/\/doi.org\/10.1007\/s00423-022-02657-8","relation":{},"ISSN":["1435-2451"],"issn-type":[{"type":"electronic","value":"1435-2451"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"assertion":[{"value":"21 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}